Global HIV Drugs Market Size study, By Medication Class (Multi-class Combination Drugs, Nucleoside Reverse Transcriptase Inhibitors (NRTIs), Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs), Protease Inhibitors (PIs), Entry Inhibitors, and HIV Integrase Strand Transfer Inhibitors), and Regional Forecasts 2020-2027

Report ID: 10346734 |

Published Date: 21 Oct 2022 |

Report Format: |

Delivery Timeline: 48-72 Business Hours

Jump to Content Request Free Sample